Active Ingredient: IBANDRONATE SODIUM
Proprietary Name: IBANDRONATE SODIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 150MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A078995
Product Number: 001
Approval Date: Mar 19, 2012
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:
Discontinued
Patent and Exclusivity Information